Funding for this research was provided by:
Received: 19 October 2018
Accepted: 6 August 2019
First Online: 14 August 2019
Ethics approval and consent to participate
: Not applicable; the database is fully de-identified and compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Given the de-identified and retrospective nature of the data and the noninterventional study design, written patient consent was neither required nor sought. Administrative permissions were not required to access the raw data.
: Not applicable; individual patient data are not presented.
: All authors met the International Committee of Medical Journal Editors (ICMJE) authorship criteria. Neither honoraria nor payments were made for authorship. TL has received consulting fees or honoraria from Allergan plc. He has also been a consultant for Merck and The Medicines Company and has received payment for lectures, including service on speaker bureaus for Allergan for work not associated with the current study. NGB, JMY, and PG are employees of Allergan. HJF is an employee of Evidera, a healthcare consulting and contract research firm. In his salaried positions, he is precluded from receiving payment or honoraria directly from organizations for services rendered. Evidera has received funding for the study from Allergan and has received funding from many other biomedical companies in support of various research studies and projects.